Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel H Greig

Showing results (251-260 of 332) with videos related to

Pageof 34
Sort By:
Neurobiology of Disease|August 25, 2016
Post-traumatic administration of the p53 inactivator pifithrin-α oxygen analogue reduces hippocampal neuronal loss and improves cognitive deficits after experimental traumatic brain injuryLing-Yu Yang, Nigel H Greig, Ya-Ni Huang, et al.
Scientific Reports|July 18, 2018
Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's diseaseShuchun Chen, Seong-Jin Yu, Yazhou Li, et al.
International Journal of Molecular Sciences|August 7, 2021
3,6'-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain InjuryPen-Sen Huang, Ping-Yen Tsai, Ling-Yu Yang, et al.
Scientific Reports|September 14, 2018
Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's diseaseShuchun Chen, Seong-Jin Yu, Yazhou Li, et al.
Plos One|March 25, 2014
Evidence of a novel mechanism for partial γ-secretase inhibition induced paradoxical increase in secreted amyloid β proteinEliza Barnwell, Vasudevaraju Padmaraju, Robert Baranello, et al.
Neuromolecular Medicine|November 14, 2007
Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in miceFrank Haberman, Sung-Chun Tang, Thiruma V Arumugam, et al.
Current Alzheimer Research|September 14, 2019
A Pilot Study of Exenatide Actions in Alzheimer's DiseaseRoger J Mullins, Maja Mustapic, Chee W Chia, et al.
Plos One|June 24, 2014
(-)-Phenserine attenuates soman-induced neuropathologyJun Chen, Hongna Pan, Cynthia Chen, et al.
Cells|July 6, 2023
The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary MicrogliaElliot J Glotfelty, Luis B Tovar-Y-Romo, Shih-Chang Hsueh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 2, 2015
Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4David Tweedie, Lital Rachmany, Vardit Rubovitch, et al.
Pageof 34

Showing results (251-260 of 332) with videos related to

Sort By:
Pageof 34
Neurobiology of Disease|August 25, 2016
Post-traumatic administration of the p53 inactivator pifithrin-α oxygen analogue reduces hippocampal neuronal loss and improves cognitive deficits after experimental traumatic brain injuryLing-Yu Yang, Nigel H Greig, Ya-Ni Huang, et al.
Scientific Reports|July 18, 2018
Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's diseaseShuchun Chen, Seong-Jin Yu, Yazhou Li, et al.
International Journal of Molecular Sciences|August 7, 2021
3,6'-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain InjuryPen-Sen Huang, Ping-Yen Tsai, Ling-Yu Yang, et al.
Scientific Reports|September 14, 2018
Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's diseaseShuchun Chen, Seong-Jin Yu, Yazhou Li, et al.
Plos One|March 25, 2014
Evidence of a novel mechanism for partial γ-secretase inhibition induced paradoxical increase in secreted amyloid β proteinEliza Barnwell, Vasudevaraju Padmaraju, Robert Baranello, et al.
Neuromolecular Medicine|November 14, 2007
Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in miceFrank Haberman, Sung-Chun Tang, Thiruma V Arumugam, et al.
Current Alzheimer Research|September 14, 2019
A Pilot Study of Exenatide Actions in Alzheimer's DiseaseRoger J Mullins, Maja Mustapic, Chee W Chia, et al.
Plos One|June 24, 2014
(-)-Phenserine attenuates soman-induced neuropathologyJun Chen, Hongna Pan, Cynthia Chen, et al.
Cells|July 6, 2023
The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary MicrogliaElliot J Glotfelty, Luis B Tovar-Y-Romo, Shih-Chang Hsueh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 2, 2015
Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4David Tweedie, Lital Rachmany, Vardit Rubovitch, et al.
Pageof 34